Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  35.00 2.12% 1,683.60 1,688.80 1,689.60 1,693.20 1,641.00 1,641.00 9,175,512 16:35:05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 17.9 84,467

Glaxosmithkline Share Discussion Threads

Showing 21101 to 21123 of 21425 messages
Chat Pages: Latest  845  844  843  842  841  840  839  838  837  836  835  834  Older
DateSubjectAuthorDiscuss
07/4/2020
14:38
Many of those up have been seriously hammered some more than 50% relatively GSK has not fallen that much.
tim 3
07/4/2020
12:50
AZN only down today sud. Overall AZN has easily outperformed GSK.
igoe104
07/4/2020
12:43
It's a risk on day, cyclicals and financials should outperform, in general terms.
essentialinvestor
07/4/2020
12:35
AZN down 2% igoe!spud
spud
07/4/2020
12:10
Christh, most stocks are up at least 5%. these are doing nothing, AV up 13.8% at the moment.
igoe104
07/4/2020
12:06
montyhedge7 Apr '20 - 10:19 - 21079 of 21084 Shareprice going nowhere. its up you idiot
christh
07/4/2020
11:09
Thursday I think you'll find igoe. spud
spud
07/4/2020
11:09
I don't know how many posters follow the presentation and disclosure of R&D costs here. Ex 1 - costs of R&D in their own labs. Ex 2a - buy in of a third party's R&D from a listed company. Ex 2b - buy in of a third party's R&D from a non listed company. Huge numbers.
alphorn
07/4/2020
11:07
23p dividend this Friday.
igoe104
07/4/2020
10:53
Still 20% down over the last couple of months. Azn less than 10% down.
igoe104
07/4/2020
10:50
A bit dull and defensive this one - my largest holding.Good and reassuring in down days but always a bit of a let down when market flying
watfordhornet
07/4/2020
10:19
Shareprice going nowhere.
montyhedge
07/4/2020
09:35
Vir market capitalisation is $4.03 bn
tradermichael
07/4/2020
08:46
What share of VIR will 250m give GSK?
watfordhornet
07/4/2020
08:41
GlaxoSmithKline PLC said Monday that it will invest $250 million in Vir Biotechnology Inc. as part of their new partnership to research and develop solutions for the treatment of coronaviruses, including the one that causes Covid-19. The British pharma group said the collaboration will use Vir's proprietary monoclonal antibody platform technology to accelerate existing and identify new anti-viral antibodies that could be used to treat coronaviruses, while GlaxoSmithKline will provide expertise in functional genomics. GlaxoSmithKline said that to gain access to Vir's technology, it will buy Vir's shares at $37.73, a 10% premium to the closing share price on Friday.
tradermichael
06/4/2020
17:43
great news for us all.
barony
06/4/2020
15:12
Over 1500p can't hold bears and profit takers pile in.
montyhedge
03/4/2020
16:46
Or cash which is still king
bc4
03/4/2020
16:31
buywell, if the world does have to press the reset button, it is probably best to be owning cash generating assets (and probably some gold tucked away in your back pocket)
crazycoops
03/4/2020
11:16
Interesting link - Chinese company that launched the first Hep E vaccine. The further the net is cast the greater the probability of finding something.
alphorn
03/4/2020
11:09
GSK To Collaborate With Xiamen Innovax Biotech To Evaluate Recombinant Protein-Based Coronavirus Vaccine Candidate – RTRS https://twitter.com/LiveSquawk/status/1246015920910340096
zho
03/4/2020
03:37
Problem is IMO after Covid-19 what Health Services in what countries are going to be able to pat $100K per year for expensive drugs ? ALL countries are going to be saddled with MASSIVE debts for the next generation Some countries will be bankrupt by Covid -19 buywell sees the world having to press the reset button dyor
buywell3
02/4/2020
14:05
TM - actives for patented drugs would almost always be produced by the drug company concerned - that is where the margin is pushed to lower group taxes. I suspect that the comment above related to the actives for low margin generics. Not to say that those drugs themselves are not important to patients.
alphorn
Chat Pages: Latest  845  844  843  842  841  840  839  838  837  836  835  834  Older
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200528 19:54:02